Seagen Inc.
SGENDelisted Dec 14, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001060736
Seagen Inc. was delisted on Dec 14, 2023; its insiders filed their last Form 4 on Dec 18, 2023; 614 institutions reported holding it in 13F filings for Q3 2023, worth $36.3B in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Seagen Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 592
- +19 vs. Q1 2023
- Shares held
- 166.5M
- +479.7K (+0.3%) vs. Q1 2023
- Total value
- $32.0B
- −$1.53B (−4.6%) vs. Q1 2023
- New holders
- 96
- 210 more added
- Sold out
- 77
- 193 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 5 | $386.8K |
| Q3 2023 | 614 | $36.3B |
| Q2 2023 | 592 | $32.0B |
| Q1 2023 | 574 | $33.6B |
| Q4 2022 | 534 | $21.4B |
| Q3 2022 | 536 | $22.2B |
| Q2 2022 | 546 | $29.0B |
| Q1 2022 | 501 | $24.0B |
| Q4 2021 | 521 | $25.4B |
| Q3 2021 | 476 | $27.9B |
| Q2 2021 | 471 | $25.5B |
| Q1 2021 | 493 | $22.3B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Seagen Inc.; share changes are against Q1 2023.